Guz, M., Jeleniewicz, W., Cybulski, M., Kozicka, J., Kurzepa, J., & Mądro, A. (2021). Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis. Biomed Rep.

Guz, Małgorzata, Witold Jeleniewicz, Marek Cybulski, Joanna Kozicka, Jacek Kurzepa, và Agnieszka Mądro. "Serum MiR-210-3p Can Be Used to Differentiate between Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis." Biomed Rep 2021.

Guz, Małgorzata, et al. "Serum MiR-210-3p Can Be Used to Differentiate between Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis." Biomed Rep 2021.